Table 1.
Basal characteristics, presence of co-morbidities, and treatment of the patients divided by pulse wave velocity median value.
| Variables | PWV ≤ 8.8 m/s | PWV > 8.8 m/s | p |
|---|---|---|---|
| No of patients | 36 | 36 | |
| Dialysis vintage, months | 123.34 ± 86.23 | 110.47 ± 81.48 | 0.520 |
| Age, years | 50.71 ± 12.26 | 61.89 ± 11.96 | 0.000 |
| Gender, males (%) | 14 | 20 | 0.119 |
| BMI, kg/m2 | 24.03 ± 4.13 | 25.31 ± 3.72 | 0.190 |
| kT/V Primary kidney disease: GN Nephroangiosclerosis APCKD Calculosis BEN Others Treatment: yes, (%) Vitamin D Phosphate binders Calcium-based ESA Anti-hypertensive drugs |
1.27 ± 0.27 6 5 5 10 2 8 12 33 16 24 |
1.25 ± 0.16 8 9 3 2 10 4 12 34 15 25 |
0.938 0.767 0.372 0.710 0.024 0.024 0.599 0.500 0.192 0.500 |
| Co-morbidities, yes, (%) | |||
| Hypertension | 26 | 20 | 0.110 |
| CVD | 7 | 12 | 0.142 |
| CVI | 4 | 2 | 0.337 |
Categorical variables are presented as absolute values; continuous normally distributed variables are presented as mean ± SD; continuous skewed variables are presented as median (interquartile range (IQR)). BMI: body mass index, kT/V: single pool urea kinetic, GN: glomerular disease, APCKD: adult polycystic kidney disease, BEN: Balkan endemic nephropathy, ESA: erythropoietin-stimulating agents, CVD: cardiovascular diseases (pre-study period: heart failure, previous myocardial infarction, aorto-coronary bypass surgery, peripheral vascular disease), CVI: cerebrovascular insult.